Quote | WPD Pharmaceuticals Inc (OTCMKTS:WPDPF)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 100 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | WPD Pharmaceuticals Inc (OTCMKTS:WPDPF)
WPD Pharmaceuticals (WPDPF) announces that it plans to commence a phase Ib/II study of berubicin for the treatment of glioblastoma ((GBM)) in the second half of this year.CNS Pharmaceuticals (CNSP), the company that sublicenses the compound to WPD for 30 countries mainly in Europe...
WPD Pharmaceuticals (WPDPF) announces that it has been conditionally awarded a grant of $6.7M from the Polish National Center for Research and Development (“NCRD”), for the development of annamycin, the company’s drug candidate used in the treatment of Acute Myeloid ...
Message Board Posts | WPD Pharmaceuticals Inc (OTCMKTS:WPDPF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |